Skip to main content
Top
Published in: The International Journal of Cardiovascular Imaging 1/2010

01-01-2010 | Original Paper

Protective modulation of carotid atherosclerosis in hyperalphalipoproteinemic individuals

Authors: F. D. Santiago, R. T. Nakamura, D. Kaplan, E. C. de Faria

Published in: The International Journal of Cardiovascular Imaging | Issue 1/2010

Login to get access

Abstract

To determine whether hyperalphalipoproteinemia modifies carotid intima-media thickness (cIMT) and/or influences the relationship of clinical and biochemical parameters with cIMT. This study was conducted on 169 asymptomatic individuals, classified as hyperalphalipoproteinemic (Hyper-A) (Hyper-A, n = 71, HDL-C ≥68 mg/dL) and controls (CTL) (CTL, n = 98, HDL-C >32 and <68 mg/dL). Enzymatic, nephelometric and ultracentrifugation methods were used for biochemical determinations. Hepatic lipase (HL), lipoprotein lipase (LPL), cholesteryl ester transfer protein (CETP) and phospholipids transfer protein (PLTP) activities were measured by radiometric exogenous methods. The prevalence of dyslipidemia, hypertension, smoking, sedentariness, postmenopausal women, coronary artery disease (CAD) and familial history of CAD were determined. High resolution β-mode carotid ultrassonography was performed. The Hyper-A group was older and had higher frequencies of hypercholesterolemia (40%), hypertension (31%), sedentariness (37%) and postmenopausal women (1%). In Hyper-A individuals, the mean cIMT after adjustment for age and gender was similar between the groups (0.85 ± 0.24 mm Hyper-A versus 0.69 ± 0.17 mm CTL). In multivariate models, age was a significant predictor of cIMT in Hyper-A (R 2 = 0.04, p ≤ 0.001), independently of other clinical or biochemical factors. In contrast to CTL, where age (R 2 = 0.63 p ≤ 0.001), male sex (R 2 = 0.03, p ≤ 0.001), blood pressure (R 2 = 0.006, p ≤ 0.001) and HDL-C (R 2 = 0.02, p < 0.022) accounted for the cIMT variations. Despite an increased prevalence of cardiovascular risk factors in Hyper-A and resistance of carotid thickness to modulation by metabolic and anthropometric factors (except age), the similarity in cIMT between Hyper-A and healthy individuals emphasizes the atheroprotective effects of HDL.
Literature
1.
go back to reference Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M et al (1997) Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987–1993. Am J Epidemiol 146(6):483–494PubMed Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M et al (1997) Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987–1993. Am J Epidemiol 146(6):483–494PubMed
2.
go back to reference Bots ML (2006) Carotid intima-media thickness as a surrogate marker for cardiovascular disease in intervention studies. Curr Med Res Opin 22(11):2181–2190CrossRefPubMed Bots ML (2006) Carotid intima-media thickness as a surrogate marker for cardiovascular disease in intervention studies. Curr Med Res Opin 22(11):2181–2190CrossRefPubMed
3.
go back to reference Zureik M, Ducimetière P, Touboul PJ, Courbon D, Bonithon-Kopp C, Berr C, Magne C (2000) Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques: longitudinal results from the Aging Vascular Study (EVA) study. Arterioscler Thromb Vasc Biol 20(6):1622–1629PubMed Zureik M, Ducimetière P, Touboul PJ, Courbon D, Bonithon-Kopp C, Berr C, Magne C (2000) Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques: longitudinal results from the Aging Vascular Study (EVA) study. Arterioscler Thromb Vasc Biol 20(6):1622–1629PubMed
4.
go back to reference Hovingh GK, de Groot E, van der Steeg W, Boekhondt SM, Hutten BA et al (2005) Inheterited disorders of HDL metabolism and atherosclerosis. Curr Opin Lipidol 16(2):139–145CrossRefPubMed Hovingh GK, de Groot E, van der Steeg W, Boekhondt SM, Hutten BA et al (2005) Inheterited disorders of HDL metabolism and atherosclerosis. Curr Opin Lipidol 16(2):139–145CrossRefPubMed
5.
go back to reference de Groot E, Hovingh GK, Wiegman A, Duriez P, Smit AJ, Fruchart JC, Kastelein JJ (2004) Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation 109(23 (Suppl 1)):III33–III38 ReviewPubMed de Groot E, Hovingh GK, Wiegman A, Duriez P, Smit AJ, Fruchart JC, Kastelein JJ (2004) Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation 109(23 (Suppl 1)):III33–III38 ReviewPubMed
6.
go back to reference Csiba L (2005) Carotid intima-media thickness measured by ultrasonography: effect of different pharmacotherapies on atherosclerosis progression. Orv Hetil 146(23):1239–1244PubMed Csiba L (2005) Carotid intima-media thickness measured by ultrasonography: effect of different pharmacotherapies on atherosclerosis progression. Orv Hetil 146(23):1239–1244PubMed
7.
go back to reference Fielding PE, Fielding CJ (1996) Intracellular transport of low-density lipoprotein derived free cholesterol begins at clathrin-coated pits and terminates at cell surface caveolae. Biochemistry 35(47):14932–14938CrossRefPubMed Fielding PE, Fielding CJ (1996) Intracellular transport of low-density lipoprotein derived free cholesterol begins at clathrin-coated pits and terminates at cell surface caveolae. Biochemistry 35(47):14932–14938CrossRefPubMed
8.
go back to reference Kontush A, Chapman MJ (2006) Antiatherogenic small, dense HDL—guardian angel of the arterial wall? Nat Clin Pract Cardiovasc Med 3(3):144–153 ReviewCrossRefPubMed Kontush A, Chapman MJ (2006) Antiatherogenic small, dense HDL—guardian angel of the arterial wall? Nat Clin Pract Cardiovasc Med 3(3):144–153 ReviewCrossRefPubMed
9.
go back to reference Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP et al (1989) High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 79(1):8–15PubMed Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP et al (1989) High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 79(1):8–15PubMed
10.
go back to reference Bruckert E, Hansel B (2007) HDL-C is a powerful lipid predictor of cardiovascular diseases. Int J Clin Pract. (61) 11: 1782–6 Bruckert E, Hansel B (2007) HDL-C is a powerful lipid predictor of cardiovascular diseases. Int J Clin Pract. (61) 11: 1782–6
11.
go back to reference Inazu A, Brown ML, Hesler CB, Agellon LB, Koizumi J et al (1990) Increased high-density-lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med 323(18):1234–1238PubMedCrossRef Inazu A, Brown ML, Hesler CB, Agellon LB, Koizumi J et al (1990) Increased high-density-lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med 323(18):1234–1238PubMedCrossRef
12.
go back to reference Sich D, Saidi Y, Giral P, Lagrost L, Egloff M, Auer C, Gautier V, Turpin G, Beucler I (1998) Hyperalphalipoproteinemia: characterization of a cardioprotective profile associating increased high-density lipoprotein2 levels and decreased hepatic lipase activity. Metabolism 47(8):965–973CrossRefPubMed Sich D, Saidi Y, Giral P, Lagrost L, Egloff M, Auer C, Gautier V, Turpin G, Beucler I (1998) Hyperalphalipoproteinemia: characterization of a cardioprotective profile associating increased high-density lipoprotein2 levels and decreased hepatic lipase activity. Metabolism 47(8):965–973CrossRefPubMed
13.
go back to reference Kontush A, de Faria EC, Chantepie S, Chapman MJ (2004) Antioxidative activity of HDL particle subspecies is impaired in hyperalphalipoproteinemia: relevance of enzymatic and physicochemical properties. Arterioscler Thromb Vasc Biol 24(3):526–533CrossRefPubMed Kontush A, de Faria EC, Chantepie S, Chapman MJ (2004) Antioxidative activity of HDL particle subspecies is impaired in hyperalphalipoproteinemia: relevance of enzymatic and physicochemical properties. Arterioscler Thromb Vasc Biol 24(3):526–533CrossRefPubMed
14.
go back to reference Yamashita S, Maruyama T, Hirano K, Sakai N, Nakajima N, Matsuzawa Y (2000) Molecular mechanisms, lipoproteins abnormalities and athero genicity of hyperalphalipoproteinemia. Atherosclereosis 152:271–285CrossRef Yamashita S, Maruyama T, Hirano K, Sakai N, Nakajima N, Matsuzawa Y (2000) Molecular mechanisms, lipoproteins abnormalities and athero genicity of hyperalphalipoproteinemia. Atherosclereosis 152:271–285CrossRef
15.
go back to reference Alarcon SBK, Oliveira HCF, Harada LM, Nunes VS, Kaplan D et al (2004) Moderate hyperalphalipoproteinemia in a Brazilian population is related to lipoprotein lipase activity, alipoprotein A-I concentration, age and body mass index. Clin Sci 106:11–17CrossRefPubMed Alarcon SBK, Oliveira HCF, Harada LM, Nunes VS, Kaplan D et al (2004) Moderate hyperalphalipoproteinemia in a Brazilian population is related to lipoprotein lipase activity, alipoprotein A-I concentration, age and body mass index. Clin Sci 106:11–17CrossRefPubMed
16.
go back to reference Kaplan DB, Schreiber R, Oliveira HC, Harada LM, Nakamura RT et al (2006) Cholesteryl ester transfer protein gene mutations in Brazilian hyperalphalipoproteinemia. Clin Gen 69(5):455–457CrossRef Kaplan DB, Schreiber R, Oliveira HC, Harada LM, Nakamura RT et al (2006) Cholesteryl ester transfer protein gene mutations in Brazilian hyperalphalipoproteinemia. Clin Gen 69(5):455–457CrossRef
17.
go back to reference Matsuzawa Y, Yamashita S, Funahashi T, Yamamoto A, Tarui S (1988) Selective reduction of cholesterol in HDL2 fraction by probucol in familial hypercholesterolemia and hyper HDL2 cholesterolemia with abnormal cholesteryl ester transfer. Am J Cardiol 62:B66–72BCrossRef Matsuzawa Y, Yamashita S, Funahashi T, Yamamoto A, Tarui S (1988) Selective reduction of cholesterol in HDL2 fraction by probucol in familial hypercholesterolemia and hyper HDL2 cholesterolemia with abnormal cholesteryl ester transfer. Am J Cardiol 62:B66–72BCrossRef
18.
go back to reference Hirano K, Yamashita S, Kuga Y, Sakai N, Nosaki S et al (1995) Atherosclerosis disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase. Aterioscler Thromb Vasc Biol 15(11):1849–1856 Hirano K, Yamashita S, Kuga Y, Sakai N, Nosaki S et al (1995) Atherosclerosis disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase. Aterioscler Thromb Vasc Biol 15(11):1849–1856
19.
go back to reference Agerholm-Larsen B, Nordestgaard BG, Steffensen R, Jensen G, Tybjaerg-Hansen A (2000) Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene. Circulation 101(16):1907–1912PubMed Agerholm-Larsen B, Nordestgaard BG, Steffensen R, Jensen G, Tybjaerg-Hansen A (2000) Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene. Circulation 101(16):1907–1912PubMed
20.
go back to reference Sposito AC, Caramelli B, Fonseca FAH, Bertolami MC (2007) IV Diretriz Brasileira Sobre Dislipidemias e Prevenção da Aterosclerose. Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia. Arquivos Brasileiros de Cardiologia 88(1): 2–19 Sposito AC, Caramelli B, Fonseca FAH, Bertolami MC (2007) IV Diretriz Brasileira Sobre Dislipidemias e Prevenção da Aterosclerose. Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia. Arquivos Brasileiros de Cardiologia 88(1): 2–19
21.
go back to reference Pedro AO, Pinto-Neto AM, Costa-Paiva LHS, Osis MJ, Hardy EE (2003) Idade de ocorrência da menopausa natural em mulheres brasileiras: resultados de um inquérito populacional domiciliar. Rev Saude Publica 37(6):735–742CrossRefPubMed Pedro AO, Pinto-Neto AM, Costa-Paiva LHS, Osis MJ, Hardy EE (2003) Idade de ocorrência da menopausa natural em mulheres brasileiras: resultados de um inquérito populacional domiciliar. Rev Saude Publica 37(6):735–742CrossRefPubMed
22.
go back to reference Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN et al (2007) Physical activity and public health. Updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation 116(9):1081–1093CrossRefPubMed Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN et al (2007) Physical activity and public health. Updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation 116(9):1081–1093CrossRefPubMed
23.
go back to reference Friedewald WF, Levy RI, Frederickson DS (1972) Estimation of LDL-cholesterol concentration without use of preparitive ultracentrifuge. Clin Chem 18:499–502PubMed Friedewald WF, Levy RI, Frederickson DS (1972) Estimation of LDL-cholesterol concentration without use of preparitive ultracentrifuge. Clin Chem 18:499–502PubMed
24.
go back to reference Eyre J, Hammett F, Miller NE (1981) A micro-method for the rapid ultracentrifugal separation of human plasma high density lipoprotein subfractions, HDL2 and HDL3. Clin Chim Acta 114(2–3):225–231CrossRefPubMed Eyre J, Hammett F, Miller NE (1981) A micro-method for the rapid ultracentrifugal separation of human plasma high density lipoprotein subfractions, HDL2 and HDL3. Clin Chim Acta 114(2–3):225–231CrossRefPubMed
25.
go back to reference Ehnholm C, Kuusi T (1986) Preparation, characterization and measurement of hepatic lipase. Methods Enzymol 129:716–738CrossRefPubMed Ehnholm C, Kuusi T (1986) Preparation, characterization and measurement of hepatic lipase. Methods Enzymol 129:716–738CrossRefPubMed
26.
go back to reference Lagrost L (1998) Determination of the mass concentration and the activity of the plasma cholesteryl ester transfer protein (CETP). Methods Mol Biol 110:231–241PubMed Lagrost L (1998) Determination of the mass concentration and the activity of the plasma cholesteryl ester transfer protein (CETP). Methods Mol Biol 110:231–241PubMed
27.
go back to reference Damen J, Regts J, Scherphorp G (1982) Transfer of [14C] phosphatidylcholine between liposomes and human plasma high density lipoprotein. Partial purification of transfer stimulation plasma factor using a rapid transfer assay. Biochim Biophys Acta 712:444–452PubMed Damen J, Regts J, Scherphorp G (1982) Transfer of [14C] phosphatidylcholine between liposomes and human plasma high density lipoprotein. Partial purification of transfer stimulation plasma factor using a rapid transfer assay. Biochim Biophys Acta 712:444–452PubMed
28.
go back to reference Simons PC, Algra A, Bots ML, Grobbee DE, van der Graaf Y (1999) Common carotid intima-media thickness and arterial stiffness: indicators of cardiovascular risk in high-risk patients. The SMART Study (Second Manifestations of arterial disease). Circulation 100(9):951–957PubMed Simons PC, Algra A, Bots ML, Grobbee DE, van der Graaf Y (1999) Common carotid intima-media thickness and arterial stiffness: indicators of cardiovascular risk in high-risk patients. The SMART Study (Second Manifestations of arterial disease). Circulation 100(9):951–957PubMed
29.
go back to reference Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Fogelman AM (2006) Mechanisms of disease: proatherogenic HDL—an evolving field. Nat Clin Pract Endocrinol Metab 2(9):504–511 ReviewCrossRefPubMed Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Fogelman AM (2006) Mechanisms of disease: proatherogenic HDL—an evolving field. Nat Clin Pract Endocrinol Metab 2(9):504–511 ReviewCrossRefPubMed
30.
go back to reference Dodani S, Kaur R, Reddy S, Reed GL, Navab M, George V (2008) Can dysfunctional HDL explain high coronary artery disease risk in South Asians? Int J Cardiol 129(1):125–132CrossRefPubMed Dodani S, Kaur R, Reddy S, Reed GL, Navab M, George V (2008) Can dysfunctional HDL explain high coronary artery disease risk in South Asians? Int J Cardiol 129(1):125–132CrossRefPubMed
31.
go back to reference Baldassamare D, Amato M, Pustina L, Tremoli H, Sirtori C, Calabresi L, Franceschini G (2002) Increased carotid artery intima-media thickness in subjects with primary hypoalphalipoproteinemia. Arterioscl Thromb Vasc Biol 22(2):317–322CrossRef Baldassamare D, Amato M, Pustina L, Tremoli H, Sirtori C, Calabresi L, Franceschini G (2002) Increased carotid artery intima-media thickness in subjects with primary hypoalphalipoproteinemia. Arterioscl Thromb Vasc Biol 22(2):317–322CrossRef
32.
go back to reference Howard G, Sharrett AR, Heiss G, Evans GW, Chambless LE, Riley WA, Burke GL (1993) Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators. Stroke 24(9):1297–1304PubMed Howard G, Sharrett AR, Heiss G, Evans GW, Chambless LE, Riley WA, Burke GL (1993) Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators. Stroke 24(9):1297–1304PubMed
33.
go back to reference Kontush A, de Faria EC, Chantepie S, Chapman MJ (2005) A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity. Atherosclerosis 182(2):277–285CrossRefPubMed Kontush A, de Faria EC, Chantepie S, Chapman MJ (2005) A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity. Atherosclerosis 182(2):277–285CrossRefPubMed
Metadata
Title
Protective modulation of carotid atherosclerosis in hyperalphalipoproteinemic individuals
Authors
F. D. Santiago
R. T. Nakamura
D. Kaplan
E. C. de Faria
Publication date
01-01-2010
Publisher
Springer Netherlands
Published in
The International Journal of Cardiovascular Imaging / Issue 1/2010
Print ISSN: 1569-5794
Electronic ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-009-9498-2

Other articles of this Issue 1/2010

The International Journal of Cardiovascular Imaging 1/2010 Go to the issue